Search

Hemant Desai

Examiner (ID: 19091)

Most Active Art Unit
3721
Art Unit(s)
3731, 3721
Total Applications
1094
Issued Applications
787
Pending Applications
41
Abandoned Applications
266

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14990671 [patent_doc_number] => 20190314293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => LOXAPINE FILM ORAL DOSAGE FORM [patent_app_type] => utility [patent_app_number] => 16/455916 [patent_app_country] => US [patent_app_date] => 2019-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3070 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 239 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16455916 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/455916
LOXAPINE FILM ORAL DOSAGE FORM Jun 27, 2019 Abandoned
Array ( [id] => 17520447 [patent_doc_number] => 20220106296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => CYANOTRIAZOLE COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/253737 [patent_app_country] => US [patent_app_date] => 2019-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31398 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253737 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/253737
CYANOTRIAZOLE COMPOUNDS AND USES THEREOF Jun 17, 2019 Abandoned
Array ( [id] => 15239447 [patent_doc_number] => 20190374509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-12 [patent_title] => Methods of Using Metamizole for Treatment of Pyrexia in Equines [patent_app_type] => utility [patent_app_number] => 16/438130 [patent_app_country] => US [patent_app_date] => 2019-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12105 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438130 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/438130
Methods of Using Metamizole for Treatment of Pyrexia in Equines Jun 10, 2019 Abandoned
Array ( [id] => 16992260 [patent_doc_number] => 20210230680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => Modified Nucleobases with Uniform H-Bonding Interactions, Homo- and Hetero-Basepair Bias, and Mismatch Discrimination [patent_app_type] => utility [patent_app_number] => 16/972873 [patent_app_country] => US [patent_app_date] => 2019-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9346 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -48 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972873 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/972873
Modified Nucleobases with Uniform H-Bonding Interactions, Homo- and Hetero-Basepair Bias, and Mismatch Discrimination Jun 6, 2019 Pending
Array ( [id] => 15264567 [patent_doc_number] => 20190381017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => Compositions Comprising Serdexmethylphenidate Conjugates And Methods Of Use Thereof [patent_app_type] => utility [patent_app_number] => 16/433525 [patent_app_country] => US [patent_app_date] => 2019-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45579 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -78 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16433525 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/433525
Compositions Comprising Serdexmethylphenidate Conjugates And Methods Of Use Thereof Jun 5, 2019 Abandoned
Array ( [id] => 17005277 [patent_doc_number] => 20210236438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => COMPOUNDS AND METHODS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROLOGICAL OR PSYCHIATRIC DISORDERS [patent_app_type] => utility [patent_app_number] => 15/734869 [patent_app_country] => US [patent_app_date] => 2019-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7779 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734869 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/734869
COMPOUNDS AND METHODS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROLOGICAL OR PSYCHIATRIC DISORDERS Jun 4, 2019 Pending
Array ( [id] => 16990111 [patent_doc_number] => 20210228531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => TARGETED TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROLOGICAL OR PSYCHIATRIC DISORDERS [patent_app_type] => utility [patent_app_number] => 15/734843 [patent_app_country] => US [patent_app_date] => 2019-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23328 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734843 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/734843
TARGETED TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROLOGICAL OR PSYCHIATRIC DISORDERS Jun 4, 2019 Pending
Array ( [id] => 16822645 [patent_doc_number] => 20210137938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => NUPR1 INHIBITION FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/059297 [patent_app_country] => US [patent_app_date] => 2019-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7756 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 244 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059297 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/059297
NUPR1 INHIBITION FOR TREATING CANCER May 30, 2019 Pending
Array ( [id] => 20414124 [patent_doc_number] => 12497394 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-16 [patent_title] => Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereof [patent_app_type] => utility [patent_app_number] => 17/057199 [patent_app_country] => US [patent_app_date] => 2019-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15368 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 505 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057199 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/057199
Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereof May 20, 2019 Issued
Array ( [id] => 15206013 [patent_doc_number] => 20190365693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => INDUCTION OF ARTERIOGENESIS [patent_app_type] => utility [patent_app_number] => 16/412749 [patent_app_country] => US [patent_app_date] => 2019-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14424 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16412749 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/412749
INDUCTION OF ARTERIOGENESIS May 14, 2019 Abandoned
Array ( [id] => 19491866 [patent_doc_number] => 12110564 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-08 [patent_title] => Test to distinguish viral-only from bacterial infection or viral/bacterial coinfection using a respiratory swab [patent_app_type] => utility [patent_app_number] => 17/052882 [patent_app_country] => US [patent_app_date] => 2019-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7797 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052882 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/052882
Test to distinguish viral-only from bacterial infection or viral/bacterial coinfection using a respiratory swab May 5, 2019 Issued
Array ( [id] => 16655892 [patent_doc_number] => 20210052528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => THE USE OF SGC ACTIVATORS AND SGC STIMULATORS FOR THE TREATMENT OF COGNITIVE IMPAIRMENT [patent_app_type] => utility [patent_app_number] => 17/051060 [patent_app_country] => US [patent_app_date] => 2019-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13193 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17051060 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/051060
THE USE OF SGC ACTIVATORS AND SGC STIMULATORS FOR THE TREATMENT OF COGNITIVE IMPAIRMENT Apr 11, 2019 Abandoned
Array ( [id] => 16374948 [patent_doc_number] => 20200323790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-15 [patent_title] => METHOD FOR TREATMENT OF ACUTE LUNG INJURY BY USE OF KIRENOL [patent_app_type] => utility [patent_app_number] => 16/382662 [patent_app_country] => US [patent_app_date] => 2019-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2290 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382662 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/382662
METHOD FOR TREATMENT OF ACUTE LUNG INJURY BY USE OF KIRENOL Apr 11, 2019 Abandoned
Array ( [id] => 18215181 [patent_doc_number] => 11590093 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-28 [patent_title] => Kit, composition, and combination therapy for fragile X syndrome [patent_app_type] => utility [patent_app_number] => 16/383037 [patent_app_country] => US [patent_app_date] => 2019-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 28 [patent_no_of_words] => 8161 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383037 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/383037
Kit, composition, and combination therapy for fragile X syndrome Apr 11, 2019 Issued
Array ( [id] => 15586247 [patent_doc_number] => 20200069658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => COMBINATION THERAPY FOR PULMONARY HYPERTENSION [patent_app_type] => utility [patent_app_number] => 16/381128 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8972 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381128 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/381128
COMBINATION THERAPY FOR PULMONARY HYPERTENSION Apr 10, 2019 Abandoned
Array ( [id] => 16374966 [patent_doc_number] => 20200323808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-15 [patent_title] => WOUND TREATMENTS AND COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/381975 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18990 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381975 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/381975
Wound treatments and compositions Apr 10, 2019 Issued
Array ( [id] => 16596510 [patent_doc_number] => 20210023041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => FORMULATIONS AND COMPOSITIONS OF DOCETAXEL [patent_app_type] => utility [patent_app_number] => 16/982772 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44214 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982772 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/982772
FORMULATIONS AND COMPOSITIONS OF DOCETAXEL Apr 10, 2019 Abandoned
Array ( [id] => 16533276 [patent_doc_number] => 10875859 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-29 [patent_title] => Thymoquinone/harmaline and related reaction products [patent_app_type] => utility [patent_app_number] => 16/380279 [patent_app_country] => US [patent_app_date] => 2019-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 8044 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16380279 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/380279
Thymoquinone/harmaline and related reaction products Apr 9, 2019 Issued
Array ( [id] => 15586171 [patent_doc_number] => 20200069620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => COMPOSITION AND METHOD FOR MUSCLE REPAIR AND REGENERATION [patent_app_type] => utility [patent_app_number] => 16/379178 [patent_app_country] => US [patent_app_date] => 2019-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20743 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16379178 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/379178
Composition and method for muscle repair and regeneration Apr 8, 2019 Issued
Array ( [id] => 16726444 [patent_doc_number] => 20210093591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => METHODS FOR MITIGATING AND PREVENTING PROTEOSTASIS-BASED INJURIES [patent_app_type] => utility [patent_app_number] => 17/043966 [patent_app_country] => US [patent_app_date] => 2019-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21406 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17043966 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/043966
METHODS FOR MITIGATING AND PREVENTING PROTEOSTASIS-BASED INJURIES Mar 28, 2019 Abandoned
Menu